Calgent Biotech

Calgent Biotech is a biotechnology company specializing in the development of rapid molecular diagnostic reagents and instruments, primarily for Point-of-Care Testing (POCT). The company's core technology is the proprietary Enzymatic Recombinase Amplification (ERA) platform, an isothermal nucleic acid amplification method that allows for highly sensitive and specific detection of pathogens at a constant temperature within 5 to 20 minutes. Calgent's product portfolio includes a wide range of diagnostic kits for infectious diseases such as COVID-19, monkeypox, and various respiratory and reproductive tract infections. By eliminating the need for complex thermal cycling equipment, Calgent aims to decentralize molecular diagnostics and provide accessible testing solutions for clinical, veterinary, and food safety applications. The company is headquartered in Suzhou Industrial Park, China, with additional research facilities in Shanghai.